Spherix (SPEX)
Spherix Price / Book Value: 0.4936
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
SPEX Price / Book Value Rankings
| Overall | 91st percentile | 350 of 4243 |
| Sector | 96th percentile | 18 of 475 in Healthcare |
| Industry | 95th percentile | 1 of 21 in Medical Laboratories & Research |
SPEX Price / Book Value Range, Past 5 Years
| Minimum | 0.4936 | May 31 2012 |
| Maximum | 57.58 | Sep 2010 |
| Average | 5.294 |
About Price to Book Ratio
The price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.
The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.
In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.
Learn More
You may also be interested in these SPEX related companies
SPEX News
Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
Apr 10, 11:05AM PR Newswire
Apr 10, 11:05AM PR Newswire
RT @idrinkchai $SPEX might holy grail here on intraday, what do you mean by that
about 86 days ago by allars
about 86 days ago by allars
Spherix (SPEX) Rips After Positive SPX-106T Data on Atherosclerotic Plaque Reduction
Mar 07, 10:19AM Street Insider
Mar 07, 10:19AM Street Insider
SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease
Mar 07, 9:15AM PR Newswire
Mar 07, 9:15AM PR Newswire
Spherix to Present at the LHA Life Sciences & Medical Technologies Virtual Conference on February 16
Feb 10, 10:42AM PR Newswire
Feb 10, 10:42AM PR Newswire
Spherix $SPEX Shares Halted on Breaker Down 22% Following $1.15M Offering
about 120 days ago by Street_Insider
about 120 days ago by Street_Insider
Spherix (SPEX) Shares Halted on Breaker Down 22% Following $1.15M Offering
Feb 02, 2:48PM Street Insider
Feb 02, 2:48PM Street Insider
Shares of Spherix Inc. (SPEX) Trade Up 40% on SPX-106 28-day Rat Toxicology Study Results
Jan 11, 11:51AM Street Insider
Jan 11, 11:51AM Street Insider
Spherix Announces Successful Completion of Important Toxicology Study of SPX-106
Jan 11, 9:47AM PR Newswire
Jan 11, 9:47AM PR Newswire
Spherix Issues Reminder of Business Update Conference Call Set for Today at Noon Eastern Time
Nov 16, 10:03AM PR Newswire
Nov 16, 10:03AM PR Newswire
$SPEX http://stks.co/9tx Showed they could reduce cholesterol levels in mice
about 266 days ago by Tr8r_x
about 266 days ago by Tr8r_x
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SPEX | 0.75 | -0.03 | -3.85% | 3.12M |
| SPCHB | 1.716 | +0.03 | +1.54% | 3.054M |
| SPCHA | 1.22 | -0.15 | -10.95% | 15.14M |
| SPBC | 12.85 | +0.00 | +0.00% | 22.23M |
| SPB | 33.10 | -1.42 | -4.11% | 1.787B |
| SPAR | 4.21 | -0.29 | -6.44% | 151.29M |
| SPAN | 17.51 | +0.01 | +0.06% | 51.10M |
| SPAB | 1.07 | +0.04 | +3.88% | |
| YGE | 2.71 | +0.11 | +4.23% | 378.53M |
| YELP | 15.58 | -1.13 | -6.76% |
